Monday's top analyst upgrades and downgrades included Alphabet, AppLovin, Facebook, Intel, Live Nation, Oracle, Pinterest, Smith & Wesson and SolarEdge.
Facebook's Oversight Board has delivered its decision on the company's banning of former President Trump from posting new material to his Facebook and Instagram accounts.
Paul Ausick Facebook blew past estimates when it reported March quarter results. How long can the company keep that up now that Apple requires apps to get permission from iPhone users to track them…
Paul Ausick The social media giant released its most recent quarterly results after the closing bell on Wednesday.
Chris Lange Earnings reports from the country's biggest tech firms continue to roll out this week.
Digital ad growth for the first quarter was very solid, and the big winners were the large-cap internet leaders that dominate the space. Three top stocks are excellent holdings for long-term aggressive…
Wednesday's top analyst upgrades and downgrades included Alphabet, Facebook, Harley-Davidson, JetBlue Airways, Lowe's Companies, Occidental Petroleum, Overstock.com, Snap and Southwest Airlines.
24/7 Wall St. looks at why ARK Invest sold Apple, Netflix and others during March.
The FANG stocks are among the top BofA Securities growth stock picks. With the market very pricey and perhaps vulnerable to tail risks, these stocks are very likely one of the best…
Monday's top analyst upgrades and downgrades included Array Technologies, Baidu, Credit Suisse, Facebook, Franklin Resources, Twitter and ViacomCBS.
One of Cathie Wood's Ark Invest funds sold over 150,000 shares of Facebook on March 19.
The more than 25 million Facebook shares sold short as of the most recent settlement date were over 9% more than the figure two weeks earlier, as well as the greatest level…
The almost 23 million Facebook shares short as of the most recent settlement date were down more than 15% from a year ago.
Analysts recommended buying shares of the following eight top tech stocks last week, though a few of these seem like contrarian calls.
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh and Palantir Technologies.
